Immunotherapy of Cancer Conference (ITOC)

The Immunotherapy of Cancer Conference (ITOC) is the leading international European meeting organized by CDDF and SITC.

The goal of the Conference is to provide a forum for discussion of early clinical drug development and address the unique challenges of immuno-oncology, with a special emphasis on clinical trials, translational research and biomarker development.

ITOC attracts a multi-stakeholder attendance connecting preclinical and clinical scientists, clinicians, healthcare professionals, academia and other stakeholders who are involved in the development of novel anticancer agents.